-
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
Thursday, January 20, 2022 - 2:39pm | 1266Read More...Key Takeaways Everest has signed a global licensing deal for an anti-viral Covid treatment being developed by Singapore’s Experimental Drug Development Centre Similar oral anti-viral treatments have been developed by Pfizer and Merck, and are growing in popularity due to their ease of use...
-
Morgan Stanley Initiates Coverage On Everest
Wednesday, December 1, 2010 - 9:52am | 88Read More...Morgan Stanley is initiating coverage of Everest Re Group, Ltd. (NYSE: RE) at Equal-weight. “Everest is a global reinsurance leader with a diversified platform and sizable excess capital on the balance sheet,” Morgan Stanley writes. “CEO Joe Taranto has driven excellent results in his tenure and is...
